Blog Archives

Methodology for a Symptomatic Impact Study Using a Portable Essential Tremor Monitor to Direct Therapeutic Interventions

P Vittal, C Pulliam, C Goetz, J Jankovic, J Ramirez-Castaneda, D Heldman 18th International Congress of Parkinson’s Disease and Movement Disorders, Stockholm, Sweden, 2014

PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with mobile apps strategically aligns with growing trends in domestic and

Read more ›

Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor

A. Espay, M. Edwards, G. Oggioni, N. Phielipp, B. Cox, H. Gonzalez-Usigli, C. Pecina, D. Heldman, J. Mishra, A. Lang Parkinsonism Relat Disord. 2014;20(6):647–50.

PRESS RELEASE: GLNT Awarded Patent For Technology To Treat Parkinson’s Disease With Brain Stimulation During Sleep

VIEW PRESS RELEASE [PDF] 22 JUL 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of stimulating the brain during sleep to treat movement disorder symptoms. The claims cover a

Read more ›

PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Develop Intelligent Algorithms for Programming Deep Brain Stimulation in Parkinson’s

VIEW PRESS RELEASE [PDF] 22 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson’s disease.   The study is being funded by a $283,828

Read more ›

PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval for Parkinson’s Assessment in Australia

VIEW PRESS RELEASE [PDF] 9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ ] includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated

Read more ›

PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS)

Read more ›

Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson’s disease

A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera Phys Sportsmed. 2011 Sep;39(3):83-93

Upper-extremity stroke therapy task discrimination using motion sensors and electromyography

J. Giuffrida, A. Lerner, R. Steiner, J. Daly IEEE Trans Neural Syst Rehabil Eng. 2008 Feb;16(1):82-90


VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, October 24, 2006 – Cleveland Medical Devices Inc. (CleveMed) has been awarded a $896,000 Phase II grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) to continue the development and clinical assessment of an Untethered

Read more ›